Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
ADVM - REVENUE
Revenue ADVM - Adverum Biotechnologies, Inc.
3.6 M
LAST VALUE
-30.72%
2 YEAR CAGR
17.43%
5 YEAR CAGR
22.32%
10 YEAR CAGR